Sana Biotechnology SANA Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.5×+0.3×

Vertex PharmaceuticalsVRTX

3.2×+0.7×

Gilead SciencesGILD

1.3×0.0×

CRISPR TherapeuticsCRSP

18×+2.3×

Allogene TherapeuticsALLO

9.6×-0.1×

Ginkgo BioworksDNA

4.6×-0.8×

FAQ

What is Sana Biotechnology's current ratio?

Sana Biotechnology (SANA) reported current ratio of 1.3× in Q1 2026.

How has Sana Biotechnology's current ratio changed year-over-year?

Sana Biotechnology's current ratio decreased by 61.9% year-over-year, from 3.4× to 1.3×.

What is the long-term trend for Sana Biotechnology's current ratio?

Over 5 years (2020 to 2025), Sana Biotechnology's current ratio has grown at a -31.2% compound annual growth rate (CAGR), from 12.2× to 1.9×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.